“…The included studies were performed among both humans and animals, assessing different types of neuromodulation interventions (i.e., ECT (Kanayama et al, 2019), tDCS (Artifon et al, 2020), dTMS (Ferrulli et al, 2021), rTMS (Seewoo et al, 2022), DBS (Lubomski et al, 2022), VNS (Phillips Campbell et al, 2016;Haney et al, 2018) in a variety of diseases (i.e., schizophrenia (Kanayama et al, 2019), overweight and sugary food cravings (Artifon et al, 2020), obesity (Ferrulli et al, 2021), PD (Lubomski et al, 2022) and disease models (i.e., amyotrophic lateral sclerosis (Haney et al, 2018), heart failure (Phillips Campbell et al, 2016), depression (Seewoo et al, 2022) (see Table 1). Neuromodulation protocols generally consisted of multiple sessions of stimulation, ranging from 14 to 30 sessions over a period of 2-10 weeks, or chronic stimulation provided for 4 to 6 several weeks, except for Haney et al (2018) which administered VNS in a single session of 1 h (Haney et al, 2018).…”